Collectively, genetic or pharmacological suppression of TRPM7/TRPM6 channels inhibits cell proliferation, underscoring the importance of these channels in promoting proliferation and pointing towards a potential therapeutic avenue for the treatment of neuroblastoma. The gene discussed is TRPM7; the disease is neuroblastoma.